
CONMED CORP
CNMDNYSE๐ #1848 by market capEarnings Nov 3 ยท PostUS Equity
$615.55โฒ $29.85 (+4.85%)
Simulated price1hโ
24hโฒ 4.8%
7dโ
14dโ
30dโ
1yโ
๐ฆMarket Cap
$1.48B
Small Cap
๐Revenue Growth (YoY)
+5.2%
Slowing
๐Gross Margin
54.8%
Healthy
๐ตFCF Margin
9.8%
Moderate
โ๏ธP/S Ratio
1.1x
Cheap
Otter Score
62
Fair
๐
Analyst Ratings
Price
$615.55
Total
21
Raised
1
Lowered
6
Avg PT
$37.50
H / L
$39 / $36
| Institution | Action | Rating | Date |
|---|---|---|---|
Piper Sandler | Reiterated | Neutral | 2026-07-30 |
Wells Fargo | Reiterated | Equal Weight | 2026-07-30 |
B of A Securities | Downgraded | Neutral โ Underperform | 2026-06-29 |
JP Morgan | Reiterated | Neutral | 2026-04-30 |
Needham | Reiterated | Hold | 2026-01-29 |
Stifel | Downgraded | Buy โ Hold | 2025-04-28 |
Keybanc | Reiterated | Overweight | 2023-07-27 |
CL King | Reiterated | Buy | 2023-05-22 |
Jefferies | Reiterated | Hold | 2022-10-12 |
UBS | Reiterated | Buy | 2021-07-15 |
Barclays | Reiterated | Overweight | 2021-05-25 |
SVB Leerink | Reiterated | Market Perform | 2020-07-30 |
Stifel Nicolaus | Reiterated | Buy | 2019-10-31 |
Piper Jaffray | Upgraded | Neutral โ Overweight | 2019-08-22 |
Ladenburg Thalmann | Downgraded | Buy โ Neutral | 2017-04-27 |
Leerink Swann | Downgraded | Outperform โ Market Perform | 2016-07-28 |
Northland Securities | Downgraded | Outperform โ Market Perform | 2015-07-22 |
Northland Capital Markets | Downgraded | Outperform โ Market Perform | 2015-07-22 |
Deutsche Bank | Reiterated | Buy | 2015-05-04 |
PiperJaffray | Reiterated | Neutral | 2015-04-23 |
KeyBanc | Reiterated | Sector Weight โ Equal Weight | 2015-03-16 |
One row per institution, most recent rating